FDA Recall Signal: One Class II Report in Sector Context

A June 2026 FDA Class II recall of a multi-ingredient gut-health supplement, cited for premature lipid oxidation, is examined alongside a dozen other 2026 enforcement reports to show how classification, stated reason, and distribution scope differ across recall types.

Abstract close-up of oxidized oil droplets representing lipid oxidation in a supplement formulation
Abstract close-up of oxidized oil droplets representing lipid oxidation in a supplement formulation

FDA Recall Signal: One Class II Report in Sector Context

Aprender › desk_industry-signals
Regresar al blog

Connected intelligence

From evidence to ingredients.

Explore the ingredient records and WQ formulas directly connected to this editorial review.

Continue the research

Latest from this journal.
Laboratory glassware and chromatography equipment representing botanical extract chemical analysis
WQ Learn

Why 2026 Botanical Research Is Chasing Chemical Standardization

Recent publications on kava, olive leaf, lavender, and turmeric reveal a shared research focus: verifying what botanical extracts actually contain through rigorous...

Read article →
Dried Andrographis paniculata plant material used in research on extracts and andrographolide
WQ Learn

Andrographis Research: Cell, Animal, and Human Evidence Compared

A structured comparison of Andrographis paniculata research — separating in vitro, animal, and human clinical findings on immune and digestive-related outcomes —...

Read article →
Stack of official government enforcement documents representing FDA and FTC supplement records
WQ Learn

FDA Recall Labeling Gap and an FTC Order: Reading the Signals

A Class II FDA recall over an undeclared fish-derived collagen source sits alongside a finalized FTC advertising order and a dozen contemporaneous...

Read article →